Difference between revisions of "2.16.840.1.113883.10.21.4.1/hgraph"

From HL7 IPS
Jump to: navigation, search
(Automated ADBot page content)
(Automated ADBot page content)
Line 97: Line 97:
 
                                             </ol>
 
                                             </ol>
 
                                         </li>
 
                                         </li>
−
                                        <li class="ad-template">
 
−
                                            <div class="nowrapinline ad-templatetype @"> @ </div> UV Dispense Request (2.16.840.1.113883.10.21.4.2)</li>
 
 
                                     </ol>
 
                                     </ol>
 
                                 </li>
 
                                 </li>

Revision as of 17:37, 26 March 2018

  1. Entry
     UV Medication Order (2.16.840.1.113883.10.21.4.1)
    1. Entry
       UV Use Period (2.16.840.1.113883.10.21.9.1)
    2. Entry
       CDA Subject (Body) (2.16.840.1.113883.10.12.320)
    3. Entry
       UV Medication Information (detail) (2.16.840.1.113883.10.21.4.11)
    4. Entry
       CDA Author (Body) (2.16.840.1.113883.10.12.318)
      1. *
         CDA Person (2.16.840.1.113883.10.12.152)
      2. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      3. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    5. Entry
       CDA Participant (Body) (2.16.840.1.113883.10.12.321)
      1. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      2. Entry
         CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    6. Entry
       CDA Participant (Body) (2.16.840.1.113883.10.12.321)
      1. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      2. Entry
         CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    7. Entry
       UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
    8. Entry
       UV Dispense Request (2.16.840.1.113883.10.21.4.2)
      1. Entry
         CDA Subject (Body) (2.16.840.1.113883.10.12.320)
      2. Entry
         CDA ManufacturedProduct (2.16.840.1.113883.10.12.312)
        1. Entry
           CDA LabeledDrug (2.16.840.1.113883.10.12.310)
        2. Entry
           CDA Material (2.16.840.1.113883.10.12.311)
        3. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      3. Entry
         CDA Performer (Body) (2.16.840.1.113883.10.12.323)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      4. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
      5. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
      6. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
      7. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    9. Entry
       Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
    10. Entry
       UV ClinicalStatement Observation (2.16.840.1.113883.10.21.4.3)
      1. Entry
         CDA Subject (Body) (2.16.840.1.113883.10.12.320)
      2. Entry
         CDA Specimen (2.16.840.1.113883.10.12.322)
      3. Entry
         CDA Performer (Body) (2.16.840.1.113883.10.12.323)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      4. Entry
         CDA Author (Body) (2.16.840.1.113883.10.12.318)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        3. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      5. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      6. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
      7. Entry
         CDA Reference (2.16.840.1.113883.10.12.324)
        1. Entry
           CDA ExternalAct (2.16.840.1.113883.10.12.325)
        2. Entry
           CDA ExternalObservation (2.16.840.1.113883.10.12.326)
        3. Entry
           CDA ExternalProcedure (2.16.840.1.113883.10.12.327)
        4. Entry
           CDA ExternalDocument (2.16.840.1.113883.10.12.328)
      8. Entry
         CDA Precondition (2.16.840.1.113883.10.12.329)
    11. Entry
       UV Substitution Permission (2.16.840.1.113883.10.21.4.5)
    12. Entry
       UV ClinicalStatement Encounter (2.16.840.1.113883.10.21.4.4)
    13. Entry
       Comment Activity (2.16.840.1.113883.10.20.22.4.64)
    14. Entry
       CDA Precondition (2.16.840.1.113883.10.12.329)
Retrieved from "http://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.10.21.4.1/hgraph&oldid=4630"